Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Showing results (271-280 of 286) with videos related to

Pageof 29
Sort By:
The New England Journal of Medicine|April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaRoland Schmitz, George W Wright, Da Wei Huang, et al.
Nature|January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR Eric Davis, Vu N Ngo, Georg Lenz, et al.
Blood Cancer Discovery|May 8, 2025
DNA methylation epitypes of Burkitt lymphoma with distinct molecular and clinical featuresNicole Thomas, Carlos A García-Prieto, Kostiantyn Dreval, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Nature|August 14, 2012
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomicsRoland Schmitz, Ryan M Young, Michele Ceribelli, et al.
Cancer Cell|November 20, 2020
Molecular Features of Cancers Exhibiting Exceptional Responses to TreatmentDavid A Wheeler, Naoko Takebe, Toshinori Hinoue, et al.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Blood|January 9, 2019
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphomaBruno M Grande, Daniela S Gerhard, Aixiang Jiang, et al.
Nature Medicine|February 26, 2020
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphomaDaisuke Ennishi, Shannon Healy, Ali Bashashati, et al.
Pageof 29

Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaRoland Schmitz, George W Wright, Da Wei Huang, et al.
Nature|January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR Eric Davis, Vu N Ngo, Georg Lenz, et al.
Blood Cancer Discovery|May 8, 2025
DNA methylation epitypes of Burkitt lymphoma with distinct molecular and clinical featuresNicole Thomas, Carlos A García-Prieto, Kostiantyn Dreval, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Nature|August 14, 2012
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomicsRoland Schmitz, Ryan M Young, Michele Ceribelli, et al.
Cancer Cell|November 20, 2020
Molecular Features of Cancers Exhibiting Exceptional Responses to TreatmentDavid A Wheeler, Naoko Takebe, Toshinori Hinoue, et al.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Blood|January 9, 2019
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphomaBruno M Grande, Daniela S Gerhard, Aixiang Jiang, et al.
Nature Medicine|February 26, 2020
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphomaDaisuke Ennishi, Shannon Healy, Ali Bashashati, et al.
Pageof 29